TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26886419

Group type: EXPERIMENTAL
Intervention: Carotid-artery stenting with embolic protection
Number of subjects: 1453

Group type: COMPARATOR
Intervention: Carotid endarterectomy
Number of subjects: 1453
Study: 24107760

Group type: EXPERIMENTAL
Intervention: Paroxetine controlled release
Number of subjects: 74

Group type: COMPARATOR
Intervention: Bupropion extended release
Number of subjects: 74
Study: 21148666

Group type: EXPERIMENTAL
Intervention: Concomitant ablation surgery (AS)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Regular cardiac surgery
Number of subjects: 132
Study: 18714251

Group type: EXPERIMENTAL
Intervention: Supine electrostimulation
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Water exercises
Number of subjects: 10

Group type: COMPARATOR
Intervention: Dry exercises
Number of subjects: 10

Group type: COMPARATOR
Intervention: Seated rest
Number of subjects: 10
Study: 17162995

Group type: EXPERIMENTAL
Intervention: 200‐mg modafinil
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 8
Study: 14566116

Group type: EXPERIMENTAL
Intervention: Exploratory laparotomy (AEL)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Diagnostic laparoscopy (ADL)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Diagnostic laparoscopy (BDL)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Expectant nonoperative management (BNOM)
Number of subjects: 102
Study: 10902983

Group type: EXPERIMENTAL
Intervention: Condensed milk + micronutrients (E)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Skimmed milk + micronutrients (M)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Skimmed milk (S)
Number of subjects: 136
Study: 9113587

Group type: EXPERIMENTAL
Intervention: Predominantly total circulatory arrest
Number of subjects: 171

Group type: COMPARATOR
Intervention: Predominantly continuous low-flow cardiopulmonary bypass
Number of subjects: 171
Study: 1609997

Group type: EXPERIMENTAL
Intervention: 50% N2O in oxygen (O2)
Number of subjects: 300

Group type: COMPARATOR
Intervention: O2 (no‐N2O group)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Craniectomy group
Number of subjects: 300

Group type: COMPARATOR
Intervention: Cervical spine surgery (CSS) group
Number of subjects: 300
Study: 3723795

Group type: EXPERIMENTAL
Intervention: Blood transfusion of 700 ml at a rate of 5 ml/min
Number of subjects: 20

Group type: COMPARATOR
Intervention: Furosemide 40 mg administered immediately before transfusion
Number of subjects: 20
Study: 30171489

Group type: EXPERIMENTAL
Intervention: Structured evidence-based physiotherapy with workplace dialogue
Number of subjects: 352

Group type: COMPARATOR
Intervention: Structured evidence-based physiotherapy (reference care)
Number of subjects: 352
Study: 27591231

Group type: EXPERIMENTAL
Intervention: 3D ultrasound-guided embryo transfer
Number of subjects: 481

Group type: COMPARATOR
Intervention: 2D ultrasound-guided embryo transfer
Number of subjects: 481
Study: 24608198

Group type: EXPERIMENTAL
Intervention: Intermittent oxaliplatin (IO) administration (eight‐cycle blocks of oxaliplatin treatment)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Calcium and magnesium salts (Ca/Mg)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Continuous oxaliplatin (CO) administration
Number of subjects: 140
Study: 22878491

Group type: EXPERIMENTAL
Intervention: Ketamine-propofol (KP)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ketamine-dexmedetomidine (KD)
Number of subjects: 60
Study: 19477537

Group type: EXPERIMENTAL
Intervention: G-CSF (Filgrastim) at a dose of 10 μg/kg body weight/day subcutaneously
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44

Group type: COMPARATOR
Intervention: G-CSF and Placebo
Number of subjects: 44
Study: 18675521

Group type: EXPERIMENTAL
Intervention: Follicular phase
Number of subjects: 22

Group type: COMPARATOR
Intervention: Luteal phase
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Progesterone levels
Number of subjects: 22
Study: 20049465

Group type: EXPERIMENTAL
Intervention: Tissue Doppler Imaging (TDI) assessment of systolic (S') and early diastolic (E') velocities of the septal and lateral mitral annulus.
Number of subjects: 60
Study: 15735188

Group type: EXPERIMENTAL
Intervention: 30 min intense exercise (65% peak oxygen uptake)
Number of subjects: 13

Group type: COMPARATOR
Intervention: No exercise (control)
Number of subjects: 13
Study: 12092938

Group type: EXPERIMENTAL
Intervention: 2-day comprehensive human sexuality seminar
Number of subjects: 422

Group type: COMPARATOR
Intervention: 3 hours of HIV prevention videos (Control)
Number of subjects: 422
Study: 9591867

Group type: EXPERIMENTAL
Intervention: terfenadine
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: loratadine
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: astemizole
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: chlorpheniramine
Number of subjects: 14
Study: 7888688

Group type: EXPERIMENTAL
Intervention: Fasting plasma glucose (FPG) cut-off point of 6.4 mM
Number of subjects: 0
Study: 3300241

Group type: EXPERIMENTAL
Intervention: Nitrendipine (20 mg/day)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Hydrochlorothiazide (50 mg/day)
Number of subjects: 18
Study: 30501727

Group type: EXPERIMENTAL
Intervention: Blunt separation method
Number of subjects: 120

Group type: COMPARATOR
Intervention: Routine longitudinal method
Number of subjects: 120
Study: 27197908

Group type: EXPERIMENTAL
Intervention: Combined home health education plus trained general practitioner intervention
Number of subjects: 1271

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 1271
Study: 23278517

Group type: EXPERIMENTAL
Intervention: Group B (balls, Subgroup B.1 - retentive anchor with gold matrix)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Group B (balls, Subgroup B.2 - retentive anchor with titanium matrix)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Group M (magnets)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Group L (locator)
Number of subjects: 69
Study: 22348650

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behaviour therapy (ICBT) for 10 weeks
Number of subjects: 101

Group type: COMPARATOR
Intervention: Attention control condition (online supportive therapy)
Number of subjects: 101
Study: 21087474

Group type: EXPERIMENTAL
Intervention: Support groups recommended by trained general practitioners (Arm B)
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: Caregiver counseling recommended by trained general practitioners (Arm C)
Number of subjects: 390

Group type: COMPARATOR
Intervention: Usual care (Arm A)
Number of subjects: 390
Study: 18516353

Group type: EXPERIMENTAL
Intervention: Calcium lactate supplementation (170 mg of calcium lactate and 60 mg of vitamin C, one tablet three times a day for four weeks)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Calcium lactate supplementation
Number of subjects: 43
Study: 16029296

Group type: EXPERIMENTAL
Intervention: Preoperative physiotherapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: No physiotherapy (Control)
Number of subjects: 60
Study: 14616171

Group type: EXPERIMENTAL
Intervention: MKC-733 (4 mg)
Number of subjects: 12
Study: 10539777

Group type: EXPERIMENTAL
Intervention: Antioxidant mixture (440 alpha‐TE, 2000 RE of beta‐carotene, 500 mg ascorbic acid, 100 microg selenium, 30 mg zinc daily)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Single antioxidant supplements (Vitamin E, Vitamin A, Vitamin C)
Number of subjects: 75
Study: 8644907

Group type: EXPERIMENTAL
Intervention: Special vessels and chlorine (5% calcium hypochlorite solution)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Special vessels only
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 42
Study: 1751573

Group type: EXPERIMENTAL
Intervention: Systematic teaching group
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Nonsystematic teaching group
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control measurement (1 week before treatment)
Number of subjects: 43
Study: 6805119

Group type: EXPERIMENTAL
Intervention: Complete parenteral nutrition for 2 days preoperatively and 6 days postoperatively
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no parenteral nutrition)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Complete parenteral nutrition
Number of subjects: 20
Study: 28949260

Group type: EXPERIMENTAL
Intervention: 100 mg CoQ10 per day for 12 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 26446784

Group type: EXPERIMENTAL
Intervention: Valcronic programme
Number of subjects: 74
Study: 25490549

Group type: EXPERIMENTAL
Intervention: Xpert MTB/RIF
Number of subjects: 24227

Group type: COMPARATOR
Intervention: Smear microscopy
Number of subjects: 24227
Study: 23098427

Group type: EXPERIMENTAL
Intervention: Tobacco promotion activities (advertising, receipt of a free sample)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: School location and low socioeconomic status
Number of subjects: 172
Study: 19895357

Group type: EXPERIMENTAL
Intervention: Sweeping of membranes
Number of subjects: 351

Group type: COMPARATOR
Intervention: No sweeping (control)
Number of subjects: 351
Study: 17666123

Group type: EXPERIMENTAL
Intervention: Calcium checklist
Number of subjects: 49

Group type: COMPARATOR
Intervention: Parent-assisted 24-h dietary recall
Number of subjects: 49
Study: 15895197

Group type: EXPERIMENTAL
Intervention: Early rheumatoid arthritis (diagnosed for less than 1 year)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Late rheumatoid arthritis (mean disease duration of 12.5 years)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Both early and late rheumatoid arthritis
Number of subjects: 133

Group type: COMPARATOR
Intervention: Long-standing rheumatoid arthritis
Number of subjects: 133
Study: 15116352

Group type: EXPERIMENTAL
Intervention: CART and MARS models
Number of subjects: 2409
Study: 10690983

Group type: EXPERIMENTAL
Intervention: Valproate (VPA) for 1 or 6 months
Number of subjects: 279

Group type: COMPARATOR
Intervention: Phenytoin for 1 week
Number of subjects: 279
Study: 9088364

Group type: EXPERIMENTAL
Intervention: Instructional guidance for observers in small social groups
Number of subjects: 149

Group type: COMPARATOR
Intervention: No instructional guidance for observers in small social groups
Number of subjects: 149

Group type: COMPARATOR
Intervention: Hosts observing large numbers in social groups
Number of subjects: 149

Group type: COMPARATOR
Intervention: Servers observing patrons in public establishments
Number of subjects: 149
Study: 8249842

Group type: EXPERIMENTAL
Intervention: piretanide 6 mg + ramipril 5 mg
Number of subjects: 480

Group type: COMPARATOR
Intervention: piretanide 3 mg
Number of subjects: 480

Group type: COMPARATOR
Intervention: piretanide 6 mg
Number of subjects: 480

Group type: COMPARATOR
Intervention: ramipril 2.5 mg
Number of subjects: 480

Group type: COMPARATOR
Intervention: ramipril 5 mg
Number of subjects: 480

Group type: COMPARATOR
Intervention: ramipril 10 mg
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: piretanide + ramipril
Number of subjects: 480

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 480
Study: 2938471

Group type: COMPARATOR
Intervention: Flurbiprofen 150 mg per day for 6 days
Number of subjects: 201

Group type: COMPARATOR
Intervention: Flurbiprofen 200 mg per day for 3 weeks
Number of subjects: 201

Group type: COMPARATOR
Intervention: Flurbiprofen 400 mg per day for 7 days
Number of subjects: 201
Study: 31431086

Group type: EXPERIMENTAL
Intervention: CEUS-CT/MR fusion imaging
Number of subjects: 268

Group type: COMPARATOR
Intervention: Routine CEUS
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: CEUS-CT/MR fusion imaging (for lesions >3 cm or close to major vessels)
Number of subjects: 268

Group type: COMPARATOR
Intervention: Routine CEUS (for lesions >3 cm or close to major vessels)
Number of subjects: 268
Study: 28803421

Group type: EXPERIMENTAL
Intervention: Quantitative coronary plaque measurements (plaque volume, plaque burden, remodeling index, diameter stenosis)
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Quantitative assessment of low CT attenuation plaque volume
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Positive remodeling
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Plaque burden
Number of subjects: 260
Study: 27367521

Group type: EXPERIMENTAL
Intervention: TB treatment
Number of subjects: 0
Study: 25143165

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.5 µg/kg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 60
Study: 22828914

Group type: EXPERIMENTAL
Intervention: Interscalene brachial plexus block
Number of subjects: 360

Group type: COMPARATOR
Intervention: Control block
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Interscalene brachial plexus block with stellate ganglion block
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Interscalene brachial plexus block without stellate ganglion block
Number of subjects: 360
Study: 20465799

Group type: EXPERIMENTAL
Intervention: Structured, tailored walking programme
Number of subjects: 146

Group type: COMPARATOR
Intervention: Treatment as usual (Control)
Number of subjects: 146
Study: 18493882

Group type: EXPERIMENTAL
Intervention: Insulin glargine (n=28)
Number of subjects: 60

Group type: COMPARATOR
Intervention: NPH insulin (n=32)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 60

Group type: COMPARATOR
Intervention: NPH insulin
Number of subjects: 60
Study: 15639633

Group type: EXPERIMENTAL
Intervention: Low-energy diet (LED 3.4MJ/day)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control diet (5MJ/day)
Number of subjects: 80
Study: 12593522

Group type: EXPERIMENTAL
Intervention: Beclometasone dipropionate (BDP) suspension for nebulization 3,200 microg day(‐1) b.i.d.
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Beclometasone dipropionate (BDP) suspension for nebulization 1,600 microg day(‐1) b.i.d.
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Beclometasone dipropionate (BDP) 800 microg day(‐1) b.i.d. via metered-dose inhaler (MDI) plus spacer
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 9445198

Group type: EXPERIMENTAL
Intervention: Fish oil (18 g of omega-3 polyunsaturated fatty acids, PUFA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 7632640

Group type: EXPERIMENTAL
Intervention: Estraderm TTS 100 micrograms twice weekly
Number of subjects: 0

Group type: COMPARATOR
Intervention: Estraderm TTS 200 micrograms twice weekly
Number of subjects: 0
Study: 2774147

Group type: EXPERIMENTAL
Intervention: Hyoscine
Number of subjects: 190

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 190
Study: 319816

Group type: EXPERIMENTAL
Intervention: Naloxone 0.1 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Naloxone 0.2 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Naloxone 0.4 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Fentanyl 0.05 mg
Number of subjects: 40
Study: 30871958

Group type: EXPERIMENTAL
Intervention: Carpal stabilizing taping (CST)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo taping (PT)
Number of subjects: 30
Study: 30139332

Group type: EXPERIMENTAL
Intervention: Email guided positive psychology intervention (PP)
Number of subjects: 275

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 275
Study: 27341028

Group type: EXPERIMENTAL
Intervention: Choline bitartrate (2.0-2.5g)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study: 24252064

Group type: EXPERIMENTAL
Intervention: Suicide prevention programme (8 sessions over 4 weeks, 2 sessions per week)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Routine treatments in the hospital (Control group)
Number of subjects: 45
Study: 22300491

Group type: EXPERIMENTAL
Intervention: Volume-Controlled Ventilation (VCV)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Pressure-Controlled Ventilation (PCV)
Number of subjects: 60
Study: 20369558

Group type: EXPERIMENTAL
Intervention: Combination of improved sex therapy and oral sildenafil for 3 months
Number of subjects: 3130

Group type: COMPARATOR
Intervention: Oral sildenafil alone for 3 months
Number of subjects: 3130
Study: 18759568

Group type: EXPERIMENTAL
Intervention: Deep Brain Stimulation (DBS)
Number of subjects: 13
Study: 15983302

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Multiple daily injections (MDI)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: CSII
Number of subjects: 107

Group type: COMPARATOR
Intervention: MDI
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: CSII and MDI
Number of subjects: 107
Study: 12456446

Group type: EXPERIMENTAL
Intervention: Gabapentin (15 mg/kg/day in 3 divided doses)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 10546710

Group type: EXPERIMENTAL
Intervention: Outpatient therapy with two 1-g doses of intramuscular ceftriaxone at 24-hour intervals followed by oral cephalexin
Number of subjects: 92

Group type: COMPARATOR
Intervention: Inpatient therapy with two 1-g doses of intramuscular ceftriaxone at 24-hour intervals followed by oral cephalexin
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Outpatient therapy
Number of subjects: 92

Group type: COMPARATOR
Intervention: Inpatient therapy
Number of subjects: 92
Study: 7573232

Group type: EXPERIMENTAL
Intervention: 200 micrograms of thyrotropin‐releasing hormone
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 400 micrograms of thyrotropin‐releasing hormone
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 26
Study: 2347114

Group type: EXPERIMENTAL
Intervention: 1% ciclopiroxolamine solution applied once daily for 1, 2, or 3 days
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 1% ciclopiroxolamine solution
Number of subjects: 6

Group type: COMPARATOR
Intervention: KOH direct microscopy
Number of subjects: 6
Study: 373072

Group type: EXPERIMENTAL
Intervention: Glucagon (0.5 mg)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Atropine (0.5 mg)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo (0.9% NaCl)
Number of subjects: 36
Study: 6670732

Group type: EXPERIMENTAL
Intervention: Fentanyl (0.1 mg)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Fentanyl (0.1 mg) and Atropine (0.01 mg/kg b.w.)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Innovar (Fentanyl (0.1 mg) and Droperidol (5 mg))
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Innovar (Fentanyl (0.1 mg) and Droperidol (5 mg)) plus Atropine (0.01 mg/kg b.w.)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (Atropine only)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Atropine-free groups with Innovar
Number of subjects: 150
Study: 30883055

Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 4614

Group type: COMPARATOR
Intervention: Vitamin K antagonist
Number of subjects: 4614

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 4614

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4614
Study: 29597112

Group type: EXPERIMENTAL
Intervention: Long version of manual teaching imagery rescripting
Number of subjects: 127

Group type: COMPARATOR
Intervention: Brief version of manual teaching imagery rescripting
Number of subjects: 127

Group type: COMPARATOR
Intervention: Wait-list control condition
Number of subjects: 127
Study: 27510595

Group type: EXPERIMENTAL
Intervention: BAI 320 μg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BAI 640 μg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MDI 640 μg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 24702835

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (81 mg per day) plus folic acid
Number of subjects: 1078

Group type: COMPARATOR
Intervention: Placebo plus folic acid
Number of subjects: 1078

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (81 mg per day) plus folic acid in original stratum
Number of subjects: 1078

Group type: COMPARATOR
Intervention: Placebo plus folic acid in original stratum
Number of subjects: 1078

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (81 mg per day) plus folic acid in expanded stratum
Number of subjects: 1078

Group type: COMPARATOR
Intervention: Placebo plus folic acid in expanded stratum
Number of subjects: 1078
Study: 22261747

Group type: EXPERIMENTAL
Intervention: BIS monitoring (BIS-open arm)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Standard monitoring of sedation only (BIS-blinded arm)
Number of subjects: 144
Study: 20951285

Group type: EXPERIMENTAL
Intervention: 2% lidocaine with 1:100,000 epinephrine
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 3% mepivacaine
Number of subjects: 50
Study: 16978666

Group type: EXPERIMENTAL
Intervention: Unidimensional rule-based condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Other two rule-based conditions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Selective attention demands
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Working memory demands
Number of subjects: 0
Study: 15848537

Group type: EXPERIMENTAL
Intervention: Daclizumab induction (2 mg/kg) on PTD 0 and 14
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Thymoglobulin induction (1.5 mg/kg) on PTD 0 and 2 followed by daclizumab on POD 14
Number of subjects: 25
Study: 12222700

Group type: EXPERIMENTAL
Intervention: Pravastatin (40 mg/day) therapy adjunctive to thrombolytic therapy
Number of subjects: 77
Study: 9788392

Group type: EXPERIMENTAL
Intervention: Biofragmentable anastomotic ring
Number of subjects: 119

Group type: COMPARATOR
Intervention: Handsewn anastomosis
Number of subjects: 119

Group type: COMPARATOR
Intervention: Elective biofragmentable anastomotic ring
Number of subjects: 119
Study: 7714788

Group type: EXPERIMENTAL
Intervention: Intravenous caffeine (0, 37.5, 75, 150 or 300 mg/70 kg)
Number of subjects: 10
Study: 2667749

Group type: EXPERIMENTAL
Intervention: Metoclopramide (M) at 4 mg/kg combined with dexamethasone (D) at 40 mg
Number of subjects: 209

Group type: COMPARATOR
Intervention: Metoclopramide (M) at 1, 2, and 4 mg/kg total dose
Number of subjects: 209
Study: 840119

Group type: EXPERIMENTAL
Intervention: Early mobilisation starting on the 7th day after myocardial infarction
Number of subjects: 201

Group type: COMPARATOR
Intervention: Control group mobilized after 3 weeks of bed rest
Number of subjects: 201

Group type: COMPARATOR
Intervention: Conservative treatment with 3 weeks of bed rest for patients not suitable for early mobilisation
Number of subjects: 201